With advances in pediatric care, the number of adolescents with chronic illnesses requiring TRT is rising sharply. The most frequent cause of delayed puberty is CDGP, which affects 2% of the population 22, 47. Although the exact incidence and prevalence are difficult to calculate, hypogonadism occurs in 20% to 80% of children treated for intracranial tumors 23, 44-46. Additional frequent causes of hypogonadism in pediatric patients include intracranial tumors and traumatic brain injury. Male production of testosterone is crucial for the development of a wide range of functions. For secondary hypogonadism, doctors treat any underlying disorder of the pituitary gland or hypothalamus. Various treatments are done depending on the cause of hypogonadism. Doctors examine the boy's penis and testes to see whether they are normally developed for his age. Research confirms the multiple anabolic effects of T, including those on bone 1, 3, 4, 22, 120. For example, the Endocrine Society recommends screening adults for polycythemia 3 and 6 months after therapy initiation. Males with Klinefelter syndrome represent the most common genetic category of primary or hypergonadotropic hypogonadism among adolescents 1, 116. The 6β-hydroxylation of testosterone is catalyzed mainly by CYP3A4 and to a lesser extent CYP3A5 and is responsible for 75 to 80% of cytochrome P450-mediated testosterone metabolism. In addition to conjugation and the 17-ketosteroid pathway, testosterone can also be hydroxylated and oxidized in the liver by cytochrome P450 enzymes, including CYP3A4, CYP3A5, CYP2C9, CYP2C19, and CYP2D6. A small portion of approximately 3% of testosterone is reversibly converted in the liver into androstenedione by 17β-HSD. In the hepatic 17-ketosteroid pathway of testosterone metabolism, testosterone is converted in the liver by 5α-reductase and 5β-reductase into 5α-DHT and the inactive 5β-DHT, respectively. It is unclear if the use of testosterone for low levels due to aging is beneficial or harmful. Testosterone is used as a medication for the treatment of male hypogonadism, gender dysphoria, and certain types of breast cancer. As demonstrated by a meta-analysis, substitution therapy with testosterone results in a significant reduction of inflammatory markers. Conflicting results have been obtained concerning the importance of testosterone in maintaining cardiovascular health. In people who have undergone testosterone deprivation therapy, testosterone increases beyond the castrate level have been shown to increase the rate of spread of an existing prostate cancer. The male brain is masculinized by the aromatization of testosterone into estradiol, which crosses the blood–brain barrier and enters the male brain, whereas female fetuses have α-fetoprotein, which binds the estrogen so that female brains are not affected. The levels remain in a pubertal range for a few months, but usually reach the barely detectable levels of childhood by 4–7 months of age. have been undertaken on the relationship between more general aggressive behavior, and feelings, and testosterone. Nearly all studies of juvenile delinquency and testosterone are not significant.|This information from Lexicomp® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider. We may earn commission from links on this page, but we only recommend products we back. "They stimulate so little muscle growth that it’s almost undetectable," says Israetel. The research on the short- and long-term risks of taking peptides is still evolving but points to hormone imbalance and even impaired pituitary function. Composed of short chains of amino acids, peptides are signaling molecules that regulate various processes from metabolism to tissue growth. This hormone, made infamous by Lance Armstrong, is produced naturally by the kidneys to stimulate red-blood-cell production.|Similar challenges face other adolescents with chronic illnesses resulting in hypogonadism 100, 101. Hypogonadism affects most adolescents and emerging adults with DMD, likely the result of the underlying condition and high-dose, chronic glucocorticoid treatment 50, 99. Addressing such questions is likely to improve the outcomes of the multiple physiological processes occurring during puberty, such as growth and bone accrual, and affect the psychosocial well-being of the treated adolescent. Various regimens of TE and oral TU increase growth rate and lead to pubertal progression without reducing adult height 11, 59, 60, 83. A body of pediatric literature supports that short-term use of intermediate-duration T esters, such as TE, and oral TU are effective and safe in puberty induction in adolescents with CDGP 11, 59, 60, 83. It has been also successfully used for managing sex transition in transgender males, although its use for pubertal induction has yet to be formally evaluated .|The TRT literature on adolescent males is limited on T-induced pubertal changes and growth. Two reports on adolescent males observed that completion and maintenance of puberty were successful with this formulation 79, 80. For this reason, the few available studies in adolescent males applied patches for a shorter time (usually for 12 hours daily) instead of the 24-hour recommended adult application 76, 77.}
.jpg)
